Skip to main content
Have a personal or library account? Click to login
E-cigarette or vaping product use-associated lung injury presenting with probable diffuse alveolar haemorrhage: A case report Cover

E-cigarette or vaping product use-associated lung injury presenting with probable diffuse alveolar haemorrhage: A case report

Open Access
|Sep 2026

Figures & Tables

Figure 1.

Chest X-ray showing non-homogeneous air-space opacities.

Figure 2.

Extensive consolidation, ground-glass densities and centrilobular nodules in both lungs.

Figure 3.

Chest X-ray shows near clearance of bilateral non-homogeneous opacities in both lung fields.

Figure 4.

Bronchoscopy picture showing fresh blood in the (A) trachea, (B) left lower lobe and (C) right lower lobe.

Table 1.

Investigation data.

ParametersResults
Haemoglobin12.8 g/dL
Total leucocyte count21.7 × 109/L
Neutrophils91%
Platelet count260 × 109/L
CRP312 mg/L
Procalcitonin47 ng/mL
Serum sodium136 mEq/L
Serum potassium3.7 mEq/L
Renal profileNormal
Liver function testNormal
Blood cultureNegative
Tracheal aspirate cultureNegative
Urine cultureNegative
Legionella antigenNegative
Viral panelNegative
Leptospira IgM/PCRNegative
TB PCRNegative
QuantiFERON-TB GoldNegative
c-ANCANegative
p-ANCANegative
HIVNegative
Hepatitis markersNegative
BAL appearanceBloody
BAL TB PCRNegative
BAL bacterial and fungal cultureNegative
BAL cytologyPlenty of RBC and few alveolar macrophages
Anti-GBM antibody1.5 IU/mL

[i] BAL, bronchoalveolar lavage. c-ANCA, cytoplasmic antineutrophil cytoplasmic antibody; CRP, C-reactive protein; HIV, human immunodeficiency virus; IgM/PCR, immunoglobulin M/polymerase chain reaction; p-ANCA, perinuclear antineutrophil cytoplasmic antibody; RBC, red blood cells; TB PCR, tuberculosis polymerase chain reaction.

Table 2.

Clinical timeline of presentation, management and outcome.

Time pointClinical events and management
Approximately 1 week before admissionDry cough, sore throat, malaise; increased vaping to approximately 10 sessions/day.
Hospital day 0High-grade fever and bilateral pulmonary opacities; antibiotics and supportive care started.
Within 3 hrSevere hypoxaemia, supraventricular tachycardia, shock, intubation; fresh blood noted in endotracheal tube.
Early ICU courseAntibiotics, vasopressors, hydrocortisone for presumed septic shock; haemoglobin fell to 5.3 g/dL; six units of packed red cells transfused.
Hospital days 1–10Extensive negative microbiological/autoimmune evaluation; gradual clinical and radiological improvement; first extubation after 10 days.
Shortly after extubationRecurrent fever, blood clots in secretions, tachypnoea, inability to clear secretions; re-intubation.
After re-intubationBronchoscopy showed blood in bilateral distal airways; bloody BAL obtained, but sequential aliquots and hemosiderin quantification were unavailable.
Three days laterImprovement with combined supportive care, antibiotics, transfusion, airway clearance and corticosteroids; successful extubation.
Fourth week of hospital stayClinically stable; cessation advised. Discharged from hospital
1 month follow upA video consultation was performed, and the patient remained asymptomatic and reported complete cessation of vaping and cigarette smoking. No recurrent respiratory symptoms were reported. Follow-up HRCT and pulmonary function testing could not be performed

[i] BAL, bronchoalveolar lavage; HRCT, high-resolution computed tomography; ICU, intensive care unit.

DOI: https://doi.org/10.2478/pneum-2026-0015 | Journal eISSN: 2247-059X | Journal ISSN: 2067-2993
Language: English, Romanian
Page range: 127 - 133
Published on: Sep 17, 2026
Published by: Romanian Society of Pneumology
In partnership with: Paradigm Publishing Services
Publication frequency: Volume open

© 2026 John Muchahary, Jamalul Azizi Bin Abdul Rahaman, Amal Raj, Sindhu Girish Chandran, published by Romanian Society of Pneumology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.